Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation

• Autor(a) principal: Sangalli-Leite, Fernanda [UNESP]
• Data de Publicação: 2016
• Outros Autores: Scorzoni, Liliana [UNESP], Alves de Paula e Silva, Ana Carolina [UNESP], da Silva, Julhiany de Fátima [UNESP], de Oliveira, Haroldo Cesar [UNESP], de Lacorte Singulani, Junya [UNESP], Gullo, Fernanda Patrícia [UNESP], Moraes da Silva, Rosangela [UNESP], Regasini, Luis Octávio [UNESP], Siqueira da Silva, Dulce Helena [UNESP], da Silva Bolzani, Vanderlan [UNESP], Fusco-Almeida, Ana Marisa [UNESP], Soares Mendes-Giannini, Maria José [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1016/j.ijantimicag.2016.07.025; http://hdl.handle.net/11449/173714
• topic: Amphotericin B; Chequerboard; Cryptococcus neoformans; Galleria mellonella; Pedalitin

Cryptococcosis is an opportunistic fungal infection responsible for high morbidity and mortality in immunocompromised patients. Combination of antifungal substances is a promising way to increase the percentage of successful treatment. Pedalitin (PED) is a natural substance obtained from Pterogyne nitens. The aim of this study was to verify the efficacy of PED alone and in combination with amphotericin B (AmB) in vitro and in vivo against Cryptococcus spp. In the in vitro assay, minimum inhibitory concentrations (MICs) of 0.125 mg/L for AmB and 3.9 mg/L for PED were found when the substances were tested alone, whilst in the combination treatment the active concentration of both decreased, with MICs of 0.03 mg/L for AmB and 1 mg/L for PED. In the survival assay, fungal burden study and histopathological assays it was possible to study the efficacy of the substances alone and in combination. The efficacy of combination therapy was considered better than monotherapy as evaluated in a Galleria mellonella model and a murine model. Thus, the combination of PED and AmB is an interesting alternative for anticryptococcal fungal treatment. Moreover, a correlation was observed between the invertebrate and murine models for this antifungal treatment combination.